Title of article :
The Clinical Outcome of Laparoscopic Surgery for Endometriosis on Pain, Ovarian Reserve, and Cancer Antigen 125 (CA-125): A Cohort Study
Author/Authors :
Sarbazi ، Fereshte Department of Obstetrics and Gynaecology - Farmanieh Hospital , Akbari ، Elham Department of Obstetrics and Gynaecology - Farmanieh Hospital , Karimi ، Anita Department of Obstetrics and Gynaecology - Farmanieh Hospital , Nouri ، Behnaz Department of Obstetrics and Gynaecology - Shohadaye Tajrish Hospital - Shahid Beheshti University of Medical Sciences , Noori Ardebili ، Shahla Department of Obstetrics and Gynaecology - Farmanieh Hospital
Abstract :
Background:Endometriosis is an important cause of chronic pain and infertility. Surgery is considered the gold standard for diagnosis and treatment. In this study, we aim to describe the clinical outcomes of women who undergo laparoscopic surgery for endometriosis. Materials and Methods: :In this cohort study, a total of 174 women who referred to Farmaniyeh Hospital, Tehran, Iran from August 2015 to December 2017 with surgical diagnoses of endometriosis stages III and IV enrolled. The participants’ demographic, gynaecological, and clinical characteristics were recorded and they were asked to use a numeric rating scale (NRS) to record their severity of pain before and three months after surgery. Blood samples were also taken from the patients before and three months after surgery for measurement of serum levels of antiMüllerian hormone (AMH) and cancer antigen 125 (CA-125). Data were analysed using SPSS version 21.Results:The patients had a mean age of 34.86 ± 6.47 years, 60.9% were married, and 49.4% were housewives. The primary indication for surgery was pain (68.4%), followed by both pain and infertility in the remainder of patients. Types of endometriotic lesions included endometrioma (19%), deep infiltrating endometriosis (DIE, 3.4%), and both endometrioma and DIE (77.6%). There was a reduction in pain from 6.79 ± 2.19 before surgery to 1.48 ± 1.68 after surgery; serum AMH levels reduced from 2.80 ± 1.86 ng/mL to 1.76 ± 1.40 ng/mL and CA 125 reduced from 257.06 ± 220.25 U/mL to 23.27 ± 23.25 U/mL (all P 0.001). Of the 21.2% who experienced recurrence, 13.5% underwent additional surgery. The total additional surgery rate was 2.8%. Of the 55 patients with infertility, 78.1% became pregnant after surgery, 54.5% of which was spontaneous.Conclusion:Surgical treatment of endometriosis had a favourable effect on the patients’ pain and inflammation and resolved the patients’ infertility with a minimal need for additional surgery.
Keywords :
AntiMullerian Hormone , CA , 125 Antigen , Endometriosis , Pain , Patient Outcome Assessment
Journal title :
International Journal of Fertility and Sterility
Journal title :
International Journal of Fertility and Sterility